Keywordscytomegalovirus; latency; immune evasion; apoptosis; gene expression; cellular signalling; antigen presentation; BAC mutagenesis; CD8 T cells; cytomegalovirus; viral immune evasion; natural killer (NK) cells; N-linked glycosylation; human cytomegalovirus; protein kinase pUL97; cyclins T1, B1 and A; protein-protein interaction; substrate phosphorylation; interaction-mediated regulation; human cytomegalovirus (HCMV); major immediate-early (MIE); IE1; protein-protein interaction; protein array; human cytomegalovirus; proteomics; mass spectrometry; virions; expression pattern; n/a; human cytomegalovirus; bacterial artificial chromosomes; essential viral genes; transfection; adenovirus; guinea pig cytomegalovirus; cytomegalovirus strain variation; CMV immune evasion; congenital cytomegalovirus infection; congenital CMV vaccines; human cytomegalovirus; UL34; sequence-specific DNA-binding protein; nuclear localization; human cytomegalovirus; tegument; assembly; HCMV; cytomegalovirus; 7-transmembrane protein; G protein-coupled receptor; GPCR; US27; UL78; virus infection; localization; guinea pig cytomegalovirus; cytomegalovirus vaccine; pentameric complex; congenital cytomegalovirus infection; baculovirus; HCMV; monocyte; macrophage; polarization; survival; signaling; receptor-ligand; viral persistence; viral dissemination; antigenic peptides; antigen presentation; CD8 T cell epitope; gene expression; immediate-early protein; murine CMV ORF m164; open reading frame; RACE mapping; reverse immunology; transcription start site; translation start site; human cytomegalovirus; homology directed repair; p53; IE72; Rad51; cytomegalovirus; genomics; transcriptomics; next-generation sequencing; drug resistance; deep sequencing; human cytomegalovirus; BAC recombineering; viral GPCR US28; virus dissemination; virus growth; membrane protein biology; HCMV; congenital; trophoblast; progenitors; neutralizing; placenta; development; neutralization; pentamer; hyperimmune globulin; cytomegalovirus; nonhuman primate; RhCMV; immune modulation; persistence; vaccine; reinfection; human cytomegalovirus; interferons; interferon g; immediate early 1; IE1; STAT1; STAT2; ND10; antiviral defense; HCMV vMIA; MAM; mitochondria; OMM; matrix; confocal microscopy; superresolution microscopy; GSTED; MSIM; PALM; CMV; lung; pneumonia; children; ground glass; HCMV; cell cycle; DNA damage response; DDR; ATM; Cytomegalovirus (CMV); Adoptive immunotherapy; T cell; immunotherapy; cellular therapy; transplant; ribozyme; RNase P; gene targeting; cytomegalovirus
